Xiaoming Dai

机构：Beth Israel Deaconess Medical Center, Nanjing Drum Tower Hospital, Nanjing University · ORCID：0000-0001-9671-8137

发表论文 66 篇 · 总被引 2808 次 · h-index 23

代表论文

• Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade (2021 · Molecular Cell · 被引 257)
• Copper Promotes Tumorigenesis by Activating the PDK1‐AKT Oncogenic Pathway in a Copper Transporter 1 Dependent Manner (2021 · Advanced Science · 被引 188)
• Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1 (2023 · Science · 被引 128)
• Exosomes from miR-29a-modified adipose-derived mesenchymal stem cells reduce excessive scar formation by inhibiting TGF-β2/Smad3 signaling (2021 · Molecular Medicine Reports · 被引 101)
• PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity (2023 · Nature Communications · 被引 80)
• Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation (2023 · Nature Cell Biology · 被引 65)